← Back to headlines
Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion in Psychedelic Foray
Eli Lilly is set to acquire AtaiBeckley for a sum of up to $3.8 billion, marking the latest venture by a major pharmaceutical company into the psychedelic drug market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
